Warning Labels The Surgeon General’s report led to the Federal ... The efficacy and acceptability of pharmacological ...

Researchers have tested a novel therapeutic concept to treat virus-induced lung failure in patients with severe COVID-19 in a phase 2 clinical trial. The approach may also be applicable to other ...

Label-free biosensor assay detects Toll-like receptor signals and even discriminates between different signaling pathways.

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...

Recently, I have been scrutinizing nutrition and supplement labels more than I normally do ... depression and has an ...

Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.

New research points to taking melatonin 3 hours before bedtime but some experts say it is still best to take the supplement ...

NeurAxis (NYSE:NRXS) announced today that the FDA granted an expanded 510(k) clearance for its IB-Stim non-implanted nerve ...

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...

Aside from Philippine bet Chelsea Manalo, the Miss Universe 2024 will see several other Filipinos raising the flag in the ...

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression completed enrolment of the double-blind phase in Q3 2024Phase 1 ...

Brilaroxazine is generally well tolerated to date in patients with acute and stable schizophrenia – – Topline data from 1-year open-label extension (OLE) trial now expected in December 2024 – ...